| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.29 | 3e-07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.26 | 2e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 4e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |